64
Participants
Start Date
November 8, 2017
Primary Completion Date
December 14, 2023
Study Completion Date
December 14, 2023
Golimumab
"Axial spondyloarthritis patients who don't have a good treatment response on 2 NSAIDs, will be treated with golimumab. After remission, the therapy will be stopped.~All patients will undergo a ileocoloscopy at baseline and, if positive, at time of remission."
Imelda Bonheiden, Bonheiden
Reuma Instituut Hasselt, Hasselt
Ghent University Hospital, Ghent
Merck Sharp & Dohme LLC
INDUSTRY
the Flanders Institute for Biotechnology
UNKNOWN
University Ghent
OTHER